Hardy Reed LLC Raises Stock Position in Stevanato Group S.p.A. (NYSE:STVN)

Hardy Reed LLC grew its stake in shares of Stevanato Group S.p.A. (NYSE:STVN) by 8.2% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 11,077 shares of the company’s stock after acquiring an additional 840 shares during the period. Hardy Reed LLC’s holdings in Stevanato Group were worth $222,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of STVN. Hilltop National Bank raised its holdings in Stevanato Group by 34.3% during the second quarter. Hilltop National Bank now owns 4,395 shares of the company’s stock worth $81,000 after purchasing an additional 1,122 shares during the last quarter. Lindenwold Advisors INC raised its stake in shares of Stevanato Group by 13.5% during the 3rd quarter. Lindenwold Advisors INC now owns 11,930 shares of the company’s stock worth $239,000 after buying an additional 1,415 shares during the last quarter. Raymond James Trust N.A. boosted its position in shares of Stevanato Group by 18.7% in the 2nd quarter. Raymond James Trust N.A. now owns 10,239 shares of the company’s stock worth $188,000 after buying an additional 1,613 shares in the last quarter. First Bank & Trust boosted its position in shares of Stevanato Group by 29.1% in the 3rd quarter. First Bank & Trust now owns 14,109 shares of the company’s stock worth $282,000 after buying an additional 3,182 shares in the last quarter. Finally, Trust Point Inc. grew its stake in Stevanato Group by 16.0% in the 3rd quarter. Trust Point Inc. now owns 23,336 shares of the company’s stock valued at $467,000 after acquiring an additional 3,222 shares during the last quarter.

Stevanato Group Stock Up 0.6 %

NYSE:STVN opened at €20.04 ($21.09) on Wednesday. Stevanato Group S.p.A. has a 12-month low of €16.56 ($17.43) and a 12-month high of €34.73 ($36.56). The company’s 50-day moving average is €19.45 and its two-hundred day moving average is €19.64. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.21 and a current ratio of 1.81.

Stevanato Group (NYSE:STVN) last announced its quarterly earnings data on Tuesday, November 5th. The company reported €0.12 ($0.13) earnings per share (EPS) for the quarter, missing the consensus estimate of €0.13 ($0.14) by (€0.01) (($0.01)). The firm had revenue of €277.90 million for the quarter, compared to analysts’ expectations of €274.36 million. Stevanato Group had a net margin of 10.47% and a return on equity of 9.86%. The business’s quarterly revenue was up 2.4% on a year-over-year basis. During the same period in the previous year, the company posted $0.16 EPS. Research analysts expect that Stevanato Group S.p.A. will post 0.5 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Separately, Citigroup reduced their price target on shares of Stevanato Group from $30.00 to $28.00 and set a “buy” rating on the stock in a report on Wednesday, August 7th.

Stevanato Group Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.